Fluid, Electrolyte and Acid-Base Imbalances

Principles of Fluid Balance and Intravenous Solutions

Maintaining fluid balance is vital for systemic perfusion and cellular function. When the body loses more fluid than it takes in, a fluid volume deficit develops. This state typically causes tachycardia, hypotension, weak thready pulses, and decreased skin turgor. Laboratory evaluations may show elevations in serum osmolality, hematocrit, and urine specific gravity as bodily fluids become more concentrated, though these specific laboratory findings depend on the underlying cause and the specific type of fluid loss.

Conversely, fluid volume excess occurs when the body retains excessive fluid, overwhelming the vascular system. Patients present with clinical signs such as hypertension, bounding peripheral pulses, jugular vein distention, and crackles noted on lung auscultation. Through hemodilution, the concentrations of hematocrit and blood urea nitrogen may decrease, although clinicians must remember that other underlying conditions can also influence these values.

Routine monitoring requires objective, highly reliable measurements. Measuring daily weights at the exact same time each day and using the very same scale provides the single most accurate routine indicator of changes in fluid status. When evaluating sudden shifts, remember that a rapid weight gain of one kilogram corresponds to approximately one liter of retained fluid.

Intravenous solutions are selected based on their tonicity to correct these fluid abnormalities. Isotonic fluids, such as 0.9% sodium chloride and lactated Ringer's solution, expand extracellular volume, including intravascular volume, without producing a substantial osmotic shift into or out of cells. Hypotonic fluids, including 0.45% sodium chloride, lower serum osmolality and promote the movement of water from the extracellular space into cells; however, rapid infusion of hypotonic solutions carries a serious risk of cellular swelling and cerebral edema. In contrast, hypertonic fluids such as 3% sodium chloride draw water from cells into the extracellular compartment, including the vascular space.

Sodium Imbalances: Hyponatremia and Hypernatremia

Sodium is the primary determinant of extracellular fluid osmolality, and its normal serum concentration ranges from 135 to 145 mEq/L. Because shifts in sodium directly affect the movement of water across the blood-brain barrier, alterations in this electrolyte prominently affect the central nervous system.

Hyponatremia occurs when serum sodium drops below 135 mEq/L. This condition primarily manifests with neurologic symptoms, including headache, confusion, altered mental status, and seizures. When managing severe symptomatic hyponatremia, priority nursing actions include initiating seizure precautions and carefully monitoring the administration of hypertonic saline. During therapy, the nurse must ensure that chronic hyponatremia is not corrected too rapidly, as rapid correction carries a grave risk of osmotic demyelination syndrome.

Hypernatremia occurs when serum sodium rises above 145 mEq/L, leading to cellular dehydration. Clinically, hypernatremia can cause pronounced thirst and lethargy; if the condition results from acute water loss, dry mucous membranes may also be observed. Just as with hyponatremia, speed of correction is critical: reducing hypernatremia too rapidly causes fluid to shift quickly back into dehydrated brain cells, which can cause cerebral edema.

Potassium Imbalances: Hypokalemia and Hyperkalemia

Potassium is the predominant intracellular cation, with a typical normal serum range of approximately 3.5 to 5.0 mEq/L, depending on the laboratory. Even minute fluctuations in extracellular potassium can destabilize excitable tissues, particularly cardiac muscle and gastrointestinal smooth muscle.

Hypokalemia presents clinically with muscle weakness, cramping, hyporeflexia, and smooth muscle slowing that manifests as constipation or paralytic ileus. Electrocardiogram (ECG) changes are distinctive and include flattened or inverted T waves, ST-segment depression, and prominent U waves. Intravenous potassium replacement requires strict adherence to safety standards: IV potassium must always be diluted and administered via an infusion pump, and it is never given as an IV push. Through a peripheral intravenous line, potassium is generally infused at no more than 10 mEq per hour; higher rates demand specific protocols and close monitoring because rapid administration can trigger dangerous dysrhythmias.

Hyperkalemia presents with muscle twitches, paresthesias, flaccid paralysis, and hyperactive bowel sounds. Characteristic ECG changes include tall peaked T waves, prolonged PR interval, widened QRS complex, and loss of P waves. When severe hyperkalemia occurs, intravenous calcium gluconate is administered immediately to stabilize myocardial cell membranes, preventing fatal arrhythmias. To shift potassium back into cells, regular insulin is administered along with intravenous dextrose. Although sodium polystyrene sulfonate removes potassium through the gastrointestinal tract, its onset is slow and unpredictable, meaning it is never an appropriate emergency treatment for life-threatening hyperkalemia.

Calcium, Phosphate, and Magnesium Dynamics

A typical normal total serum calcium range is approximately 8.5 to 10.5 mg/dL, depending on the laboratory. Calcium regulates neuromuscular transmission, cardiac electrophysiology, and skeletal integrity. Hypocalcemia increases neuromuscular excitability, producing tetany, paresthesias, and hyperactive reflexes. Classic assessment signs include a positive Chvostek sign, which is facial twitching elicited by tapping the facial nerve anterior to the ear, and a positive Trousseau sign, defined as carpal spasm induced by inflating a blood pressure cuff above systolic pressure for three minutes. On an ECG, hypocalcemia causes a prolonged QT interval, which significantly elevates the risk of dysrhythmias.

Hypercalcemia, in contrast, decreases neuromuscular excitability. Patients frequently exhibit lethargy, muscle weakness, constipation, and nephrolithiasis. Serum calcium and phosphate concentrations often vary inversely, although this inverse relationship is not invariable. When severe hyperphosphatemia develops, it can drive down serum calcium levels, precipitating clinical symptoms of hypocalcemia such as tetany and paresthesias.

Magnesium balance closely mirrors calcium behavior. Normal serum magnesium ranges between 1.3 and 2.1 mEq/L. Hypomagnesemia increases neuromuscular excitability, leading to tremors, hyperactive deep tendon reflexes, and seizures, while significantly increasing the patient's risk for the life-threatening ventricular dysrhythmia torsades de pointes. Conversely, hypermagnesemia depresses neuromuscular function, causing diminished deep tendon reflexes, bradycardia, and dangerous respiratory depression. When signs of severe magnesium toxicity appear, intravenous calcium gluconate serves as the primary antidote.

Acid-Base Balance and Systemic Homeostasis

Systemic pH depends on a tight balance between respiratory regulation of carbon dioxide and renal handling of bicarbonate. Normal arterial blood values consist of a pH of 7.35 to 7.45, a partial pressure of carbon dioxide (PaCO2) of 35 to 45 mm Hg, and an arterial bicarbonate (HCO3) of 22 to 26 mEq/L. Evaluating these parameters systematically reveals the underlying disturbance and any physiological compensation.

Respiratory acidosis is initiated by a primary rise in PaCO2, usually resulting from hypoventilation, which drives the arterial pH below 7.35 unless compensatory mechanisms restore it to normal. Common clinical causes include opioid overdose, a COPD exacerbation with carbon dioxide retention, and severe chest trauma. Conversely, respiratory alkalosis is driven by a primary fall in PaCO2 secondary to hyperventilation, causing the pH to rise above 7.45 unless compensated. Precipitating events include severe anxiety, panic attacks, mechanical overventilation, and exposure to high altitude.

Metabolic acidosis is defined by a primary decrease in bicarbonate, often falling below 22 mEq/L, which reduces the arterial pH below 7.35 unless compensated. Clinical etiologies include diabetic ketoacidosis, severe diarrhea, renal failure, and lactic acidosis. To compensate for metabolic acidosis, ventilation increases to lower PaCO2; deep, rapid Kussmaul respirations may occur when the acidosis is severe. Metabolic alkalosis involves a primary increase in bicarbonate, typically above 26 mEq/L, pushing the pH above 7.45 unless compensated; this disorder is commonly caused by gastric acid loss from prolonged nasogastric suctioning or persistent vomiting.

Interpreting compensation is essential for comprehensive care. In uncompensated acid-base disorders, the pH remains abnormal while the compensating parameter stays within normal limits. In fully compensated disorders, the arterial pH returns to normal while both PaCO2 and HCO3 remain abnormal. Additionally, acid-base status directly alters potassium distribution: acidosis, particularly mineral metabolic acidosis, can shift potassium from inside cells out into the extracellular fluid to cause hyperkalemia, though this varies by cause; conversely, alkalosis shifts potassium out of the extracellular fluid and into cells, directly predisposing patients to hypokalemia.